MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keab906

Медицинская библиотека · Rheumatology (Oxford, England) · 2022

Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.

Min Minoesch, Walter Anne W, Lim Johan, Eftimov Filip, Verhamme Camiel, de Visser Marianne, van Schaik Ivo N, Aggarwal Rohit, de Haan Rob J, van der Kooi Anneke J, Raaphorst Joost, Dutch Myositis Network

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the clinimetric properties of the Academic Medical Centre Disability Score (ALDS) in patients with idiopathic inflammatory myopathy (IIM).

METHODS

We used prospectively collected data of IIM patients who completed a phase-2 study with first-line IVIG monotherapy. The ALDS is a patient-reported questionnaire which contains 25 items relevant for disability in myositis. ALDS and all core set measures (CSMs) for myositis [including HAQ-Disability Index (HAQ-DI)] were evaluated at baseline and 9 weeks follow-up. In addition, the 2016 ACR/EULAR myositis response criteria outcome called Total Improvement Score (TIS) was evaluated at 9 weeks. We examined floor/ceiling effects, reliability and construct validity of the ALDS. To examine known-group validity, ALDS change scores over time were compared with TIS and physician impression of clinical response.

RESULTS

Nineteen patients with IIM [median age 59 years, 12 (63%) female] were enrolled. At baseline, ALDS showed a median score of 65.4 (IQR 58.2-73.5), good Cronbach's alpha (α = 0.84) and a small ceiling effect (11%). Construct validity was confirmed by moderate to strong correlations between ALDS and HAQ-DI [rs = -0.57 (baseline); -0.86 (follow-up)]. ALDS change score correlated with TIS (rs = 0.70), discriminated between responders and non-responders (TIS ≥ 40; P = 0.001), between groups based on physician impression of clinical response (P = 0.03), and detected deterioration.

CONCLUSION

The ALDS showed promising clinimetric properties and detected relevant changes in disability in patients with myositis. These results warrant further investigations.

Для цитирования: Min Minoesch, Walter Anne W, Lim Johan, Eftimov Filip, Verhamme Camiel, de Visser Marianne, van Schaik Ivo N, Aggarwal Rohit, de Haan Rob J, van der Kooi Anneke J, Raaphorst Joost, Dutch Myositis Network. Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.. Rheumatology (Oxford, England). 2022. DOI: 10.1093/rheumatology/keab906.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.